Annabel Azevedo-Silva

Ms. Annabel Azevedo-Silva


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DADeivison Silva Argolo
Deivison Silva Argolo
LOLucas Matheus Gonçalves de Oliveira
Lucas Matheus Gonçalves de Oliveira
CSCleonice Creusa Dos Santos
Cleonice Creusa Dos Santos
LGLilian Vanessa Gonçalves
Lilian Vanessa Gonçalves
ELErick Loiola
Erick Loiola
MCMaria de Fátima Dias Costa
Maria de Fátima Dias Costa
The cells in the central nervous system (CNS) can adapt to injury and inflammation through structural and functional changes, many of which are mediated by the kynurenine pathway (KP). Studies using glia–neuron co-cultures showed that the biflavonoid agathisflavone (FAB), purified from the leaves of Cenostigma pyramidale Tul., a plant native to the Brazilian caatinga, exerts strong neuroprotective effects. This study evaluated whether agathisflavone (1 µM) modulates these responses in human and murine astrocytes and microglia exposed to inflammatory activation with lipopolysaccharide (LPS, 1 µg/mL), excitotoxic activation of NMDA receptors with quinolinic acid (QUIN, 500 µM), or inhibition of the KP rate-limiting enzyme indoleamine 2,3-dioxygenase 1 (IDO1) with 1-methyl tryptophan (1-MT, 1.5 μM). Co-treatment with FAB increased astrocyte viability relative to LPS, QUIN, or 1-MT alone, by up to 35% (p < 0.05), while reducing GFAP overexpression and other features of reactive astrogliosis. FAB decreased the proportion of Iba-1+ microglia, indicating anti-inflammatory effects. When combined with QUIN or 1-MT, FAB reversed the elevation of iNOS (p < 0.0001) and reduced IL1β upregulation. FAB also modulated KP activity in a cell type-specific manner. In astrocytes, FAB with QUIN or with 1-MT increased IDO activity, whereas in microglia, FAB alone reduced it. In microglia, kynurenine-3-monooxygenase (KMO) expression was significantly increased under FAB+QUIN or FAB+1-MT (p < 0.0001). Finally, astrocyte-conditioned medium from FAB-treated cells increased the viability of neuron-like PC12 cells by up to 40%. Collectively, these findings show that FAB confers cytoprotective and anti-inflammatory actions on glial cells, modulates KP signalling in a context-dependent manner, and supports neuronal survival under neuroinflammatory conditions.

5 October 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
AAAnnabel Azevedo-Silva
Annabel Azevedo-Silva
SCSônia Carine Cova Costa
Sônia Carine Cova Costa
CBCarla Rodrigues Cardoso Branco
Carla Rodrigues Cardoso Branco
IRIsabella Mary Alves Reis
Isabella Mary Alves Reis
TSTânia Regina dos Santos Silva
Tânia Regina dos Santos Silva
ABAlexsandro Branco
Alexsandro Branco
The Marcetia species are well adapted to semi-arid regions and stand out as promising sources of phenolic compounds, including flavonoids, with potential photoprotective properties. The aim of this study was to investigate the photoprotective potential of a standardized extract of Marcetia latifolia leaves for potential application in a sunscreen formulation (UV-A and UV-B). The crude ethanolic extract of M. latifolia leaves (EEML) was standardized to contain 16.48 g of quercetin and 5.23 g of calycopterin per kg of plant and incorporated into a lotion based on Polawax®. The EEML was evaluated for its photoprotective potential by determining its flavonoid content, antioxidant activity, in vitro SPF and toxicity, with a view to its subsequent incorporation into a cosmetic formulation. The extract showed high flavonoid content, combined with relevant antioxidant activity and SPF values (13 and 7.12 at concentrations of 250 and 125 μg/μL, respectively). It also showed UVA photoprotective potential, with only 7.62% degradation of the RVS. In the HET-CAM test, EEML showed low irritant potential (IS: 2.43). The formulations containing the EEML showed satisfactory physicochemical characteristics after organoleptic, centrifugation and spreadability tests. The formulations showed satisfactory SPF and photoprotective performance. These results indicate the feasibility of using the EEML as a sunscreen in pharmaceutical preparations.